The influence of ABC pumps in anthracycline pharmacokinetics has been suggested in vitro [70,80] and studies in other cancers [47], but a population pharmacokinetic study performed in AML failed to reproduce these findings with ABCB1 and ABCG2 polymorphisms [68]. This evidence concerns the gene ABCB1 and acute myeloid leukemia.